Vanguard Group Inc. lowered its position in Addus HomeCare Co. (NASDAQ:ADUS - Free Report) by 0.5% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 1,412,981 shares of the company's stock after selling 6,740 shares during the quarter. Vanguard Group Inc. owned about 7.79% of Addus HomeCare worth $177,117,000 at the end of the most recent reporting period.
Several other hedge funds and other institutional investors have also recently bought and sold shares of the company. Bridge City Capital LLC grew its stake in shares of Addus HomeCare by 0.8% in the 4th quarter. Bridge City Capital LLC now owns 36,451 shares of the company's stock valued at $4,569,000 after buying an additional 302 shares during the period. LPL Financial LLC lifted its holdings in Addus HomeCare by 75.6% in the fourth quarter. LPL Financial LLC now owns 7,884 shares of the company's stock valued at $988,000 after acquiring an additional 3,393 shares during the last quarter. KLP Kapitalforvaltning AS purchased a new position in Addus HomeCare in the fourth quarter worth approximately $476,000. American Century Companies Inc. increased its stake in Addus HomeCare by 695.8% during the fourth quarter. American Century Companies Inc. now owns 284,346 shares of the company's stock worth $35,643,000 after acquiring an additional 248,613 shares during the last quarter. Finally, Teacher Retirement System of Texas raised its position in Addus HomeCare by 34.3% in the fourth quarter. Teacher Retirement System of Texas now owns 88,994 shares of the company's stock valued at $11,155,000 after purchasing an additional 22,738 shares during the period. 95.35% of the stock is currently owned by institutional investors and hedge funds.
Addus HomeCare Trading Down 0.9 %
ADUS traded down $0.92 during trading hours on Friday, hitting $100.85. 194,173 shares of the company's stock were exchanged, compared to its average volume of 163,298. The firm has a market cap of $1.83 billion, a P/E ratio of 23.08, a price-to-earnings-growth ratio of 1.41 and a beta of 0.93. Addus HomeCare Co. has a 12-month low of $87.88 and a 12-month high of $136.72. The firm has a 50 day moving average of $101.16 and a 200 day moving average of $118.07.
Addus HomeCare (NASDAQ:ADUS - Get Free Report) last posted its quarterly earnings data on Monday, February 24th. The company reported $1.26 earnings per share for the quarter, missing analysts' consensus estimates of $1.35 by ($0.09). The company had revenue of $297.14 million for the quarter, compared to analysts' expectations of $291.04 million. Addus HomeCare had a return on equity of 9.62% and a net margin of 6.50%. As a group, research analysts expect that Addus HomeCare Co. will post 4.59 EPS for the current fiscal year.
Analysts Set New Price Targets
A number of equities analysts have recently weighed in on the company. Stephens reiterated an "overweight" rating and set a $142.00 price target on shares of Addus HomeCare in a report on Wednesday, March 12th. JMP Securities reaffirmed a "market outperform" rating and set a $150.00 target price on shares of Addus HomeCare in a research note on Thursday. Citizens Jmp upgraded shares of Addus HomeCare to a "strong-buy" rating in a research report on Monday, December 16th. Oppenheimer upped their price objective on shares of Addus HomeCare from $145.00 to $150.00 and gave the stock an "outperform" rating in a report on Friday, January 24th. Finally, Macquarie reiterated an "outperform" rating and issued a $129.00 target price on shares of Addus HomeCare in a report on Thursday, February 27th. One investment analyst has rated the stock with a sell rating, one has issued a hold rating, seven have assigned a buy rating and two have given a strong buy rating to the company. Based on data from MarketBeat.com, the company has a consensus rating of "Moderate Buy" and a consensus price target of $132.78.
View Our Latest Analysis on Addus HomeCare
About Addus HomeCare
(
Free Report)
Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.
Recommended Stories

Before you consider Addus HomeCare, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Addus HomeCare wasn't on the list.
While Addus HomeCare currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.